Paper39655951
Deubiquitinase USP37 enhances the anti-HIV-2/SIV ability of the host restriction factor SAMHD1.
Cui W and 8 others. J Virol, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Deubiquitinase USP37 enhances the anti-HIV-2/SIV ability of the host restriction factor SAMHD1. Papers, record 39655951. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39655951
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Deubiquitinase USP37 enhances the anti-HIV-2/SIV ability of the host restriction factor SAMHD1.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Endopeptidases | Major topic |
| SAM Domain and HD Domain-Containing Protein 1 | Major topic |
| HIV-2 | Major topic |
| HIV Infections | Major topic |
| Simian Acquired Immunodeficiency Syndrome | Major topic |
| Humans | |
| Cells, Cultured | |
| Ubiquitin | |
| Protein Binding | |
| Mutation | |
| Phosphorylation |
Source PubMed
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27296872 | USP37 deubiquitinates Cdt1 and contributes to regulate DNA replication. | Mol Oncol | 2016 | https://conductscience.org/library/papers/27296872 | PubMed |
| 2 | 31492497 | Defective modulation of LINE-1 retrotransposition by cancer-associated SAMHD1 mutants. | Biochem Biophys Res Commun | 2019 | https://conductscience.org/library/papers/31492497 | PubMed |
| 3 | 22403383 | Natural SIV hosts: showing AIDS the door. | Science | 2012 | https://conductscience.org/library/papers/22403383 | PubMed |
| 4 | 10649986 | AIDS as a zoonosis: scientific and public health implications. | Science | 2000 | https://conductscience.org/library/papers/10649986 | PubMed |
| 5 | 18516089 | Atypical ubiquitin chains: new molecular signals. 'Protein Modifications: Beyond the Usual Suspects' review series. | EMBO Rep | 2008 | https://conductscience.org/library/papers/18516089 | PubMed |
| 6 | 18495778 | Vpx is critical for reverse transcription of the human immunodeficiency virus type 2 genome in macrophages. | J Virol | 2008 | https://conductscience.org/library/papers/18495778 | PubMed |
| 7 | 36782089 | Phosphorylation of USP29 by CDK1 Governs TWIST1 Stability and Oncogenic Functions. | Adv Sci (Weinh) | 2023 | https://conductscience.org/library/papers/36782089 | PubMed |
| 8 | 25284584 | USP37 directly deubiquitinates and stabilizes c-Myc in lung cancer. | Oncogene | 2015 | https://conductscience.org/library/papers/25284584 | PubMed |
| 9 | 24217394 | Structural insight into dGTP-dependent activation of tetrameric SAMHD1 deoxynucleoside triphosphate triphosphohydrolase. | Nat Commun | 2013 | https://conductscience.org/library/papers/24217394 | PubMed |
| 10 | 34518219 | Therapeutic inhibition of USP9x-mediated Notch signaling in triple-negative breast cancer. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/34518219 | PubMed |
| 11 | 23208507 | The deubiquitinating enzyme USP37 regulates the oncogenic fusion protein PLZF/RARA stability. | Oncogene | 2013 | https://conductscience.org/library/papers/23208507 | PubMed |
| 12 | 22284954 | The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx. | Cell Host Microbe | 2012 | https://conductscience.org/library/papers/22284954 | PubMed |
| 13 | 24183309 | Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. | Lancet Neurol | 2013 | https://conductscience.org/library/papers/24183309 | PubMed |
| 14 | 22884395 | Allosteric post-translational modification codes. | Trends Biochem Sci | 2012 | https://conductscience.org/library/papers/22884395 | PubMed |
| 15 | 38582329 | Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatment. | Biochim Biophys Acta Rev Cancer | 2024 | https://conductscience.org/library/papers/38582329 | PubMed |
| 16 | 17041142 | Going wild: lessons from naturally occurring T-lymphotropic lentiviruses. | Clin Microbiol Rev | 2006 | https://conductscience.org/library/papers/17041142 | PubMed |
| 17 | 26101254 | The de-ubiquitylating enzymes USP26 and USP37 regulate homologous recombination by counteracting RAP80. | Nucleic Acids Res | 2015 | https://conductscience.org/library/papers/26101254 | PubMed |
| 18 | 24035396 | Modulation of LINE-1 and Alu/SVA retrotransposition by Aicardi-Goutières syndrome-related SAMHD1. | Cell Rep | 2013 | https://conductscience.org/library/papers/24035396 | PubMed |
| 19 | 30297740 | Primate immunodeficiency virus proteins Vpx and Vpr counteract transcriptional repression of proviruses by the HUSH complex. | Nat Microbiol | 2018 | https://conductscience.org/library/papers/30297740 | PubMed |
| 20 | 28202763 | Inhibition of Vpx-Mediated SAMHD1 and Vpr-Mediated Host Helicase Transcription Factor Degradation by Selective Disruption of Viral CRL4 (DCAF1) E3 Ubiquitin Ligase Assembly. | J Virol | 2017 | https://conductscience.org/library/papers/28202763 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41662332 | Ultrarare Variants in DNA Damage Repair and Mitochondrial Genes in Pediatric Acute-Onset Neuropsychiatric Syndrome and Acute Behavioral Regression in Neurodevelopmental Disorders. | Dev Neurosci | 2026 | https://conductscience.org/library/papers/41662332 | PubMed |
| 40568704 | The emerging roles of ubiquitin-like modifications in regulating HIV replication and host defense. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/40568704 | PubMed |
| 40202047 | Grand Challenges on HIV/AIDS in China - The 5th Symposium, Yunnan 2024. | Emerg Microbes Infect | 2025 | https://conductscience.org/library/papers/40202047 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MUL1 | 79594 | PubTator's text mining | https://conductscience.org/library/genes/79594 | NCBI Gene |
| SAMHD1 | 25939 | PubTator's text mining | https://conductscience.org/library/genes/25939 | NCBI Gene |
| TRIM21 | 6737 | PubTator's text mining | https://conductscience.org/library/genes/6737 | NCBI Gene |
| USP37 | 57695 | PubTator's text mining | https://conductscience.org/library/genes/57695 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39655951
GET https://conductscience.org/api/papers/v1/39655951/references?page=2